MX2024002133A - Procesos de purificacion por cromatografia de intercambio cationico de flujo continuo para conjugados anticuerpo-farmaco. - Google Patents

Procesos de purificacion por cromatografia de intercambio cationico de flujo continuo para conjugados anticuerpo-farmaco.

Info

Publication number
MX2024002133A
MX2024002133A MX2024002133A MX2024002133A MX2024002133A MX 2024002133 A MX2024002133 A MX 2024002133A MX 2024002133 A MX2024002133 A MX 2024002133A MX 2024002133 A MX2024002133 A MX 2024002133A MX 2024002133 A MX2024002133 A MX 2024002133A
Authority
MX
Mexico
Prior art keywords
flow
exchange chromatography
drug conjugates
antibody drug
purification processes
Prior art date
Application number
MX2024002133A
Other languages
English (en)
Spanish (es)
Inventor
Rachel Hendricks
Matthew Henry Hutchinson
Mark Frederick Fedesco
Benjamin Phu Tran
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2024002133A publication Critical patent/MX2024002133A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
MX2024002133A 2021-08-23 2022-08-22 Procesos de purificacion por cromatografia de intercambio cationico de flujo continuo para conjugados anticuerpo-farmaco. MX2024002133A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163236170P 2021-08-23 2021-08-23
PCT/US2022/075252 WO2023028446A1 (en) 2021-08-23 2022-08-22 Flow through cation exchange chromatography purification processes for antibody drug conjugates

Publications (1)

Publication Number Publication Date
MX2024002133A true MX2024002133A (es) 2024-03-06

Family

ID=83271094

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024002133A MX2024002133A (es) 2021-08-23 2022-08-22 Procesos de purificacion por cromatografia de intercambio cationico de flujo continuo para conjugados anticuerpo-farmaco.

Country Status (12)

Country Link
US (1) US20240277859A1 (enExample)
EP (1) EP4392433A1 (enExample)
JP (1) JP2024532238A (enExample)
KR (1) KR20240046733A (enExample)
CN (1) CN117881686A (enExample)
AR (1) AR126847A1 (enExample)
AU (1) AU2022332274A1 (enExample)
CA (1) CA3229079A1 (enExample)
IL (1) IL310556A (enExample)
MX (1) MX2024002133A (enExample)
TW (1) TW202323268A (enExample)
WO (1) WO2023028446A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118290513B (zh) * 2024-06-05 2025-03-14 东曜药业有限公司 一种去除抗体偶联药物中游离小分子的阴离子柱层析方法及抗体偶联药物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1869065T3 (da) 2005-03-11 2020-06-08 Wyeth Llc Fremgangsmåde til kromatografi med svag opdeling
WO2012059308A1 (en) * 2010-11-01 2012-05-10 Dsm Ip Assets B.V. Single unit ion exchange chromatography antibody purification
SG10201701224UA (en) 2012-03-12 2017-04-27 Merck Patent Gmbh Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode
CN104208719B (zh) * 2014-09-24 2017-05-03 北京天广实生物技术股份有限公司 一种抗体偶联药物的阳离子交换层析纯化方法
US20180311375A1 (en) * 2017-04-27 2018-11-01 Cadila Healthcare Limited Process of preparing antibody-drug conjugate

Also Published As

Publication number Publication date
AU2022332274A1 (en) 2024-02-15
EP4392433A1 (en) 2024-07-03
IL310556A (en) 2024-03-01
AR126847A1 (es) 2023-11-22
US20240277859A1 (en) 2024-08-22
CA3229079A1 (en) 2023-03-02
KR20240046733A (ko) 2024-04-09
TW202323268A (zh) 2023-06-16
CN117881686A (zh) 2024-04-12
WO2023028446A1 (en) 2023-03-02
JP2024532238A (ja) 2024-09-05

Similar Documents

Publication Publication Date Title
Quadros et al. The protein and the gene encoding the receptor for the cellular uptake of transcobalamin-bound cobalamin
ES2784749T3 (es) Purificación de inmunoglobulina con el uso de etapas de limpieza previa
PH12013501128A1 (en) Antibody purification by cation exchange chromatography
MX2013004720A (es) Purificacion de anticuerpos mediante cromatografia de intercambio ionico de una uncia unidad.
JP2015537212A5 (enExample)
MX364908B (es) Purificación de proteínas usando amortiguador bis-tris.
EA201592192A1 (ru) Способ очистки моноклональных антител
Matte Approaches to the purification, analysis and characterization of antibody-based therapeutics
HRP20200482T1 (hr) Dijagnostičke analize i setovi za detekciju folat receptora 1
RU2016112549A (ru) Способ для повторного использования хроматографии
JP2016530533A5 (enExample)
Harris New insights into placental iron transport.
RU2015122726A (ru) ОПОСРЕДОВАННАЯ ИОННОЙ СИЛОЙ рН-ГРАДИЕНТНАЯ ИОНООБМЕННАЯ ХРОМАТОГРАФИЯ
Yagi et al. Improved secretion of glycoproteins using an N-glycan-restricted passport sequence tag recognized by cargo receptor
RU2018121657A (ru) ПРОТИВОПОЛОЖНЫЕ ГРАДИЕНТЫ pH-СОЛЬ ДЛЯ УЛУЧШЕННОГО РАЗДЕЛЕНИЯ БЕЛКОВ
US10920182B2 (en) Affinity-based analytical purification of biotherapeutics for bioprocess monitoring
MY157846A (en) Process for the purification of fc-containing proteins
HRP20251240T1 (hr) Postupak proizvodnje proteina
IL310556A (en) Purification processes using cation exchange chromatography for drug-antibody conjugates
CN107525880A (zh) 一种利拉鲁肽的超高效液相色谱分析方法
Jagschies Continuous capture of mAbs—Points to consider and case studies
US20240183859A1 (en) System and method for online detection of a post-translational modification of a polypeptide
Saito et al. Separation and analysis of charged isomers of monoclonal immunoglobulin G by ceramic hydroxyapatite chromatography
CN109096363A (zh) 一种线性pH梯度缓冲液及其应用
EA201400024A1 (ru) Хроматографическая очистка антитела в одном устройстве